Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.43 +0.08 (+0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Cash & Current Investments (2013 - 2026)

Updated

Amphastar Pharmaceuticals' Cash & Current Investments was $290.12 million in Q2 2026, up 25.2% from $231.75 million a year earlier but down 0.6% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Amphastar Pharmaceuticals came in at $282.81 million, up 27.6% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $221.65 million in FY2024 (-13.7%), $256.81 million in FY2023 (+46.1%), $175.76 million in FY2022 (+28.6%) and $136.67 million in FY2021 (+29.4%).
  • Quarterly Cash & Current Investments has moved between $114.63 million (Q3 2021) and $299.88 million (Q3 2023) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for five straight quarters, with growth averaging 5.5% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q3 2023 (growth of 62.9%); the worst was Q1 2025 (a decline of 18.2%).
  • Per Business Quant data, AMPH's Cash & Current Investments in the three quarters before Q2 2026 was $291.95 million (Q1 2026), $282.81 million (Q4 2025) and $276.21 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Amphastar Pharmaceuticals 1.08 Bn -59.50 Mn 93.47 Mn 290.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 290.12 Mn
Mar 31, 2026 291.95 Mn
Dec 31, 2025 282.81 Mn
Sep 30, 2025 276.21 Mn
Jun 30, 2025 231.75 Mn
Mar 31, 2025 236.88 Mn
Dec 31, 2024 221.65 Mn
Sep 30, 2024 250.49 Mn
Jun 30, 2024 217.78 Mn
Mar 31, 2024 289.56 Mn
Dec 31, 2023 256.81 Mn
Sep 30, 2023 299.88 Mn
Jun 30, 2023 163.14 Mn
Mar 31, 2023 192.89 Mn
Dec 31, 2022 175.76 Mn
Sep 30, 2022 184.09 Mn
Jun 30, 2022 183.39 Mn
Mar 31, 2022 187.01 Mn
Dec 31, 2021 136.67 Mn
Sep 30, 2021 114.63 Mn
API Access

Amphastar Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AMPH&period=max&api_key=YOUR_API_KEY